Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
Novo builds heart failure case for semaglutide
BioPharma Dive
Fri, 08/30/24 - 11:31 am
Novo Nordisk
obesity
semaglutide
cardiovascular disease
Medicare Coverage of Novo’s Semaglutide for CVD Could Cost $145B Annually: Study
BioSpace
Tue, 08/27/24 - 11:32 am
Novo Nordisk
cardiovascular disease
Medicare
semaglutide
Wegovy
Ozempic
Ozempic on Wall Street's list for 2027 Medicare drug negotiations
Reuters
Fri, 08/23/24 - 10:59 am
Ozempic
Novo Nordisk
Pfizer
GSK
Medicare
drug pricing
Does Ozempic increase the risk of suicidal thoughts? A new study muddles the picture
Stat
Tue, 08/20/24 - 11:11 am
Novo Nordisk
Ozempic
Wegovy
suicidal ideation
Novo Nordisk to build $220 mln raw materials plant in Denmark
Reuters
Fri, 08/16/24 - 11:20 am
Novo Nordisk
Novo Nordisk Pharmatech
Denmark
drug manufacturing
IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
Doctors struggle to get Wegovy for older Americans with heart disease
Reuters
Thu, 08/15/24 - 11:41 am
Novo Nordisk
Medicare
Wegovy
physicians
weight loss
5 Obesity Readouts to Watch in the Second Half of 2024
BioSpace
Tue, 08/13/24 - 11:47 am
obesity
clinical trials
Novo Nordisk
CagriSema
Amgen
MariTide
Monlunabant
Aphaia Pharma
APHD-012
Terns Pharmaceuticals
TERN-601
Novo Nordisk plots 2024 FDA filing for once-weekly insulin and semaglutide combo
Fierce Pharma
Mon, 08/12/24 - 06:01 pm
Novo Nordisk
FDA
insulin
semaglutide
Icosema
Weight-loss drugs like Wegovy may help stave off some cancers
NPR
Mon, 08/12/24 - 11:28 am
cancer
GLP-1 agonist
Wegovy
Zepbound
Novo Nordisk
Eli Lilly
Pharma execs react to final drug price negotiations with Medicare
Pharma Voice
Fri, 08/9/24 - 11:21 am
Medicare
drug pricing
Inflation Reduction Act
Bristol Myers Squibb
Eli Lilly
JNJ
Bayer
Merck
AstraZeneca
Novartis
Amgen
AbbVie
Novo Nordisk
Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half
Pharma Voice
Thu, 08/8/24 - 11:07 am
Big Pharma
JNJ
AbbVie
Pfizer
Roche
Eli Lilly
Novo Nordisk
Merck
Novo Nordisk pulls its FDA heart failure submission for Wegovy, will reapply early next year
Fierce Pharma
Wed, 08/7/24 - 11:47 am
Novo Nordisk
heart failure
obesity
Wegovy
FDA
Novo Nordisk’s GLP-1 sales surge, but Q2 earnings disappoint
Medical Marketing and Media
Wed, 08/7/24 - 11:45 am
Novo Nordisk
earnings
Access is unequal to weight-loss drugs Ozempic and Wegovy: study
Axios
Mon, 08/5/24 - 11:08 am
Novo Nordisk
Ozempic
Wegovy
patient access
insurers
Medicaid
Medicare
weight loss
Novo Nordisk launches weight-loss drug Wegovy in Australia
Reuters
Thu, 08/1/24 - 11:11 pm
Novo Nordisk
Wegovy
Australia
weight loss
Novo Loses IRA Case as NJ Judge Asserts Price Negotiations Are Voluntary
BioSpace
Thu, 08/1/24 - 11:41 am
Novo Nordisk
legal
drug pricing
Inflation Reduction Act
Oxford Nanopore rises on Novo Holdings equity stake
Pharmaphorum
Thu, 08/1/24 - 11:09 am
Oxford Nanopore
Novo Holdings
Novo Nordisk
Patients push back against Novo Nordisk move to scrap an insulin product
Reuters
Tue, 07/30/24 - 06:37 pm
Novo Nordisk
diabetes
insulin
Levemir
long-acting insulin
patients
Novo’s Older GLP-1 Drug Slows Cognitive Decline in Phase IIb Alzheimer’s Trial
BioSpace
Tue, 07/30/24 - 11:48 am
Novo Nordisk
liraglutide
clinical trials
Alzheimer's disease
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »